SIGA TECHNOLOGIES INC (SIGA)

4.68 -0.03 (-0.53%)

As of 2026-05-22 14:59:45 EST

SIGA Technologies, Inc. is an American pharmaceutical company founded in 1995, based in New York City, which develops and sells pharmaceutical solutions for the antiviral treatment of smallpox, monkeypox, cowpox, and vaccinia complications.

Traded asNasdaq: SIGA
ISINUS8269171067
CIK0001010086
LEI—
EIN133864870
Sector—
IndustryPharmaceutical Preparations
CEODiem Nguyen, Ph.D.
Employees39
Fiscal Year End1231
Address31 EAST 62ND STREET, NEW YORK, NY, 10065
Phone212-672-9100
Websitehttp://siga.com
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
SIGASIGA TECHNOLOGIES INC2026-05-22 14:59:454.68-0.03-0.53
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
SIGA0001010086SIGA TECHNOLOGIES INCUS8269171067—133864870Nasdaq2834Pharmaceutical Preparations1231DE31 EAST 62ND STREETNEW YORKNY10065UNITED STATESUS212-672-910031 EAST 62ND STREET, NEW YORK, NY, 1006531 EAST 62ND STREET, NEW YORK, NY, 10065SIGA PHARMACEUTICALS INC—1995-12-28Diem Nguyen, Ph.D.39http://siga.com302,150,07571,724,09771,724,097SIGA Technologies, Inc. is an American pharmaceutical company founded in 1995, based in New York City, which develops and sells pharmaceutical solutions for the antiviral treatment of smallpox, monkeypox, cowpox, and vaccinia complications.2026-05-21 18:04:03
This is a preview of the latest data. Subscribe to access the full data.
SIGA Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
SIGA Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
2025302,150,075-48,982,809-13.949971,644,400207,4730.2904
2024351,132,884120,180,62852.03771,436,927345,3110.4857
2023230,952,256-318,914,456-57.998571,091,616-1,109,553-1.5368
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Larry MillerCorporate Secretary, General Counsel2025695,250347,625463,495001,538,982
Diem Nguyen, Ph.D.Director, Chief Executive Officer2025927,000463,5001,853,992003,244,492
Daniel J. LuckshireChief Financial Officer, Executive Vice President2025752,252564,189250,776001,567,217
Dennis E. HrubyChief Scientific Officer, Executive Vice President2025748,527561,395249,506001,559,428
Phillip L. GomezChief Executive Officer202471,72866,799000138,527
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
202549
202446
202345
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202520242023
Revenue94,574,902138,719,350139,917,220
Cost Of Revenue29,703,89331,289,22917,825,090
Gross Profit64,871,009107,430,121122,092,130
Research And Development Expenses19,956,15912,310,79716,427,942
General And Administrative Expenses21,212,69425,136,05022,043,023
Operating Expenses70,872,74668,736,07656,296,055
Operating Income23,702,15669,983,27483,621,165
Net Income23,279,14359,214,21668,068,826
Earnings Per Share Basic0.330.830.95
Earnings Per Share Diluted0.320.820.95
Weighted Average Shares Outstanding Basic71,528,04371,253,17271,362,209
Weighted Average Shares Outstanding Diluted71,867,62771,905,71271,679,270
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202520242023
Cash And Cash Equivalents154,966,414155,400,262150,145,844
Marketable Securities Current———
Accounts Receivable3,263,73621,166,12921,130,951
Inventories49,054,87349,563,88064,218,337
Non Trade Receivables———
Other Assets Current5,571,8414,914,6133,496,028
Total Assets Current212,856,864231,044,884238,991,160
Marketable Securities Non Current———
Property Plant And Equipment1,090,8241,298,4231,331,708
Other Assets Non Current192,893240,6832,083,535
Total Assets Non Current6,610,57013,292,14215,361,695
Total Assets219,467,434244,337,026254,352,855
Accounts Payable824,5221,340,3371,456,316
Deferred Revenue10,240,00010,330,80020,788,720
Short Term Debt———
Other Liabilities Current6,520,0575,640,11010,181,810
Total Liabilities Current17,992,57925,331,61354,117,745
Long Term Debt———
Other Liabilities Non Current2,653,283——
Total Liabilities Non Current2,653,2833,200,6503,376,203
Total Liabilities20,645,86228,532,26357,493,948
Common Stock7,1617,1407,109
Retained Earnings-43,070,803-22,838,012-38,943,622
Accumulated Other Comprehensive Income———
Total Shareholders Equity198,821,572215,804,763196,858,907
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202520242023
Depreciation And Amortization562,607538,421538,293
Share Based Compensation Expense3,683,3633,640,1412,052,462
Other Non Cash Income Expense———
Change In Accounts Receivable-17,902,39335,178-24,276,009
Change In Inventories846,312-15,342,65325,524,485
Change In Non Trade Receivables———
Change In Other Assets———
Change In Accounts Payable-578,641-5,739,4791,996,838
Change In Other Liabilities———
Cash From Operating Activities43,471,45348,761,80794,799,331
Purchases Of Marketable Securities———
Sales Of Marketable Securities———
Acquisition Of Property Plant And Equipment———
Acquisition Of Business———
Other Investing Activities———
Cash From Investing Activities-355,009-42,450-21,686
Tax Withholding For Share Based Compensation433,763799,895214,794
Payments Of Dividends43,511,93443,108,60632,135,118
Issuance Of Common Stock—00
Repurchase Of Common Stock0011,072,511
Issuance Of Long Term Debt———
Repayment Of Long Term Debt———
Other Financing Activities———
Cash From Financing Activities-43,550,292-43,464,939-43,422,423
Change In Cash-433,8485,254,41851,355,222
Cash At End Of Period154,966,414155,400,262150,145,844
Income Taxes Paid8,200,973——
Interest Paid———
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202520242023
Earnings Per Share0.330.830.95
Price To Earnings Ratio18.51527.2415.8947
Earnings Growth Rate-60.241-12.6316106.5217
Price Earnings To Growth Ratio-0.3074-0.57320.0553
Book Value Per Share2.77963.02872.7586
Price To Book Ratio2.19811.98432.03
Ebitda32,042,72359,752,63768,607,119
Enterprise Value———
Dividend Yield0.09960.10070.0804
Dividend Payout Ratio1.86910.7280.4721
Debt To Equity Ratio———
Capital Expenditures355,008505,13621,687
Free Cash Flow43,116,44548,256,67194,777,644
Return On Equity0.11710.27440.3458
One Year Beta0.6241.45711.0538
Three Year Beta0.90641.05850.9242
Five Year Beta0.90070.83790.8194
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
Miller Larry R.General Counsel2026-03-256,920A55,438
Miller Larry R.General Counsel2026-03-253,526D51,912
Miller Larry R.General Counsel2026-03-256,920D6,921
Hruby Dennis EEVP & Chief Scientific Officer2026-03-1354,942A54,942
Luckshire Daniel JExecutive VP & CFO2026-03-1311,503A286,567
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
SEGALL BRYANT & HAMILL, LLC2026-03-311,463,343273,5225.35
CIM INVESTMENT MANAGEMENT INC2026-03-31130,42824,3795.35
JANUS HENDERSON GROUP PLC2026-03-311,003,237187,5215.35
EverSource Wealth Advisors, LLC2026-03-311,0812025.3515
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM2026-03-3111,8932,2235.35
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
AQR Funds2026-03-31Class R6QSERX81,844437,865.40.2929
AQR Funds2026-03-31Class NQSMNX81,844437,865.40.2929
AQR Funds2026-03-31Class IQSMLX81,844437,865.40.2929
Bridge Builder Trust2026-03-31Bridge Builder Small/Mid Cap Growth FundBBGSX6,52734,919.450.0004
Bridge Builder Trust2026-03-31Bridge Builder Small/Mid Cap Value FundBBVSX3,01216,114.20.0002
This is a preview of the latest data. Subscribe to access the full data.